Cynthia Seidel-Dugan

Person

Belmont, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Activatable cytokine polypeptides and methods of use thereof
- Patent number 12,076,371
- Issue date Sep 3, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable cytokine polypeptides and methods of use thereof
- Patent number 12,036,266
- Issue date Jul 16, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,981,716
- Issue date May 14, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Separation moieties and methods of use thereof
- Patent number 11,739,132
- Issue date Aug 29, 2023
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,535,658
- Issue date Dec 27, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin 12 polypeptides and methods of use thereof
- Patent number 11,453,710
- Issue date Sep 27, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TIGIT antigen-binding proteins and methods of use thereof
- Patent number 11,453,720
- Issue date Sep 27, 2022
- Potenza Therapeutics, Inc.
- Nels P. Nielson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin-2 polypeptides and methods of use thereof
- Patent number 11,352,403
- Issue date Jun 7, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-neuropilin antigen-binding proteins and methods of use thereof
- Patent number 11,186,644
- Issue date Nov 30, 2021
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-GITR antigen-binding proteins and methods of use thereof
- Patent number 10,988,545
- Issue date Apr 27, 2021
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable interleukin-2 polypeptides
- Patent number 10,696,724
- Issue date Jun 30, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable interleukin 12 polypeptides
- Patent number 10,696,723
- Issue date Jun 30, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TIGIT antigen-binding proteins and methods of use thereof
- Patent number 10,507,244
- Issue date Dec 17, 2019
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunomodulatory oncolytic adenoviral vectors, and methods of produ...
- Patent number 10,232,053
- Issue date Mar 19, 2019
- Trieza Therapeutics, Inc.
- Daniel Hicklin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-neuropilin antigen-binding proteins and methods of use thereof
- Patent number 10,227,413
- Issue date Mar 12, 2019
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
IL-2 PRODRUG
- Publication number 20240374687
- Publication date Nov 14, 2024
- Werewolf Therapeutics, Inc.
- Jose Andres SALMERON-GARCIA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240358796
- Publication date Oct 31, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240262880
- Publication date Aug 8, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDUCIBLE IL-2 AND PD-1/PD-L1 COMBINATION THERAPY
- Publication number 20240216470
- Publication date Jul 4, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDUCIBLE CYTOKINE PRODRUG AND PD-1/PD-L1 COMBINATION THERAPY
- Publication number 20240216505
- Publication date Jul 4, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERFERON POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240216474
- Publication date Jul 4, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240174725
- Publication date May 30, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE IL-12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240043488
- Publication date Feb 8, 2024
- Werewolf Therapeutics, Inc.
- William WINSTON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Activatable Cytokine Polypeptides and Methods of Use Thereof
- Publication number 20240033326
- Publication date Feb 1, 2024
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20230374093
- Publication date Nov 23, 2023
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SEPARATION MOIETIES AND METHODS OF USE THEREOF
- Publication number 20230272028
- Publication date Aug 31, 2023
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20230056051
- Publication date Feb 23, 2023
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20230051423
- Publication date Feb 16, 2023
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20220324930
- Publication date Oct 13, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SEPARATION MOIETIES AND METHODS OF USE THEREOF
- Publication number 20220220181
- Publication date Jul 14, 2022
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NEUROPILIN ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20220098312
- Publication date Mar 31, 2022
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20220056096
- Publication date Feb 24, 2022
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20210403524
- Publication date Dec 30, 2021
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY ONCOLYTIC ADENOVIRAL VECTORS, AND METHODS OF PRODU...
- Publication number 20210393803
- Publication date Dec 23, 2021
- Trieza Therapeutics, Inc.
- Daniel HICKLIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-GITR ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20210269542
- Publication date Sep 2, 2021
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20210130430
- Publication date May 6, 2021
- Werewolf Therapeutics, Inc.
- William WINSTON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SEPARATION MOIETIES AND METHODS OF USE THEREOF
- Publication number 20210115102
- Publication date Apr 22, 2021
- Werewolf Therapeutics, Inc.
- William WINSTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20200283490
- Publication date Sep 10, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20200283489
- Publication date Sep 10, 2020
- Werewolf Therapeutics, Inc.
- William Winston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TIGIT ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20200101158
- Publication date Apr 2, 2020
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TIGIT ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20200095324
- Publication date Mar 26, 2020
- Potenza Therapeutics, Inc.
- Nels P. Nielson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOMODULATORY ONCOLYTIC ADENOVIRAL VECTORS, AND METHODS OF PRODU...
- Publication number 20200014798
- Publication date Jan 9, 2020
- Trieza Therapeutics, Inc.
- Daniel HICKLIN
- H04 - ELECTRIC COMMUNICATION TECHNIQUE
Information Patent Application
Immunomodulatory Oncolytic Adenoviral Vectors, and Methods of Produ...
- Publication number 20190142967
- Publication date May 16, 2019
- Trieza Therapeutics, Inc.
- Daniel Hicklin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Anti-Neuropilin Antigen-Binding Proteins and Methods of Use Thereof
- Publication number 20190119389
- Publication date Apr 25, 2019
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-GITR Antigen-Binding Proteins and Methods of Use Thereof
- Publication number 20180208665
- Publication date Jul 26, 2018
- Potenza Therapeutics, Inc.
- Daniel Hicklin
- C07 - ORGANIC CHEMISTRY

Cynthia Seidel-Dugan

Person

Patents Grantslast 30 patents

Activatable cytokine polypeptides and methods of use thereof

Activatable cytokine polypeptides and methods of use thereof

Activatable interleukin-2 polypeptides and methods of use thereof

Separation moieties and methods of use thereof

Activatable interleukin-2 polypeptides and methods of use thereof

Activatable interleukin 12 polypeptides and methods of use thereof

Anti-TIGIT antigen-binding proteins and methods of use thereof

Activatable interleukin-2 polypeptides and methods of use thereof

Anti-neuropilin antigen-binding proteins and methods of use thereof

Anti-GITR antigen-binding proteins and methods of use thereof

Activatable interleukin-2 polypeptides

Activatable interleukin 12 polypeptides

Anti-TIGIT antigen-binding proteins and methods of use thereof

Immunomodulatory oncolytic adenoviral vectors, and methods of produ...

Anti-neuropilin antigen-binding proteins and methods of use thereof

Patents Applicationslast 30 patents

IL-2 PRODRUG

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

INDUCIBLE IL-2 AND PD-1/PD-L1 COMBINATION THERAPY

INDUCIBLE CYTOKINE PRODRUG AND PD-1/PD-L1 COMBINATION THERAPY

ACTIVATABLE INTERFERON POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE IL-12 POLYPEPTIDES AND METHODS OF USE THEREOF

Activatable Cytokine Polypeptides and Methods of Use Thereof

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

SEPARATION MOIETIES AND METHODS OF USE THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF

SEPARATION MOIETIES AND METHODS OF USE THEREOF

ANTI-NEUROPILIN ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

IMMUNOMODULATORY ONCOLYTIC ADENOVIRAL VECTORS, AND METHODS OF PRODU...

ANTI-GITR ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

ACTIVATABLE CYTOKINE POLYPEPTIDES AND METHODS OF USE THEREOF

SEPARATION MOIETIES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN-2 POLYPEPTIDES AND METHODS OF USE THEREOF

ACTIVATABLE INTERLEUKIN 12 POLYPEPTIDES AND METHODS OF USE THEREOF

ANTI-TIGIT ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

ANTI-TIGIT ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

IMMUNOMODULATORY ONCOLYTIC ADENOVIRAL VECTORS, AND METHODS OF PRODU...

Immunomodulatory Oncolytic Adenoviral Vectors, and Methods of Produ...

Anti-Neuropilin Antigen-Binding Proteins and Methods of Use Thereof

Anti-GITR Antigen-Binding Proteins and Methods of Use Thereof